The global colchicine tablet market size is expected to reach USD 2,552.84 Million in 2030 and register a revenue CAGR of 8.4%, according to the latest report by Reports and Data. Some key factors such as increasing incidences of gout across the globe and increasing prevalence of other related diseases such as Familial Mediterranean Fever (FMF) and arthritis are factors driving global market revenue growth.  An increase in the number of clinical trials for colchicine tablet has had a positive impact on the discovery of therapeutic alternatives for a variety of conditions, including cardiovascular diseases, COVID-19 symptom treatment, and others.

colchicine tablet is an alkaloid medication that was first licensed by the Food and Drug Administration (FDA) in 1961 and is mostly used to treat gout attacks. Gout is characterized by joint discomfort and inflammation, and it is caused by an excess of uric acid collecting in joints in the form of needle-like crystals. Gout is simply a severe form of inflammatory arthritis.

An increase in clinical trials for colchicine tablet is setting a trend that researchers say is encouraging the development of new medicines that is expected to aid pharmaceutical companies and consumers. In the last ten years or more, clinical trials for colchicine tablet have increased dramatically, and North America and Asia Pacific countries have emerged as one of the top global locations for clinical studies.

Get a sample of the report @

Some Key Factors Contributing to the Global Pharma & Healthcare Market Growth

Unprecedented revenue growth of the global pharma & healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health & wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in R&D activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Some Key Highlights from the Report:

    • Based on dosage formulation, the solid segment accounted for the largest revenue share in 2021 and is expected to continue to contribute major revenue share over the forecast period. The solid dosage form of colchicine tablet is preferred owing to its ease in preparation, more stable than other forms, appropriate for a long-term release, and easy handling.
    • Based on application, the Familial Mediterranean Fever segment is expected to account for a substantially large revenue share during the forecast period. colchicine tablet is so successful at preventing FMF and the development of amyloidosis that accurate diagnosis and treatment are the most critical parts of medical care.
    • On the basis of route of administration, the topical segment is expected to register a robust revenue CAGR throughout the forecast period, owing to evaluation parameter that is considered for topical dosage form are stability, penetrability, solvent property, and others.
    • Based on age, the geriatric segment is expected to account for a substantially large revenue share during the forecast period. Geriatrics are more likely to be prone to Gout arthritis resulting in one of the driving factors for the colchicine tablet market among seniors.
    • On the basis of sales channels, the online pharmacies segment is expected to register a robust revenue CAGR throughout the forecast period, owing to its rising popularity because of its ease and convenience.
    • Based on end-user, the hospitals & clinics segment is expected to account for a substantially large revenue share during the forecast period. Growth of the hospitals & clinics segment is attributed to the increasing number of hospitals in emerging Asian economies.
    • North America accounted for the largest revenue share in the global colchicine tablet market during the forecast period owing to increasing occurrences of gout and pain-related disorders, as well as the rising prevalence of gout treatments in the US
    • Asia Pacific is expected to register a robust revenue CAGR throughout the forecast period, owing to increasing research and development activities in the region and the growing geriatric population, which is expected to boost the incidence of gout.

Top Players in the Global colchicine tablet Market:

Cipla Inc., Cardinal Health, Alchem International, Medinova AG, Odan Laboratories Ltd., Prasco Laboratories, Rhea Pharmaceutical, Takeda Pharmaceuticals, Romeg Therapeutics, LLC, Endo International plc, Mylan Pharmaceuticals Inc., West-Ward Pharmaceuticals, and Wockhardt, among others.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.  

To know more about the report @ tablet-market

colchicine tablet Market Segmentation:

Dosage Formulation Outlook (Revenue, USD Million, 2019 - 2030)

  • Solid
  • Semisolid Gel
  • Liquid

Application Outlook (Revenue, USD Million, 2019 - 2030)

  • Actinic Keratosis
  • Gout
  • Behcet's Disease
  • Dermatitis Herpetiformis
  • Familial Mediterranean Fever
  • Paget's Disease
  • Other Applications  

Route of Administration Outlook (Revenue, USD Million, 2019 - 2030)

  • Oral
  • Topical

Age Outlook (Revenue, USD Million, 2019 - 2030)

  • Pediatric
  • Adult
  • Geriatric

Sales Channel Outlook (Revenue, USD Million, 2019 - 2030)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

End-User Outlook (Revenue, USD Million, 2019 - 2030)

  • Hospitals & Clinics
  • Other End-Users

Global colchicine tablet Market Report: Regional Segmentation

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Request customization of the report @

Read More Reports:

Generic Injectables Market:

Tuberculosis Testing Market:

Surgical Needle Market:

Botulinum Toxin Injection Market:

Brain Bionics Market:

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problem provide our clients with the ability to secure an edge over their respective competitors.